CS logo
small CS logo
Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica

Milano, Lombardia, Italy
Research institute in Milan
Via Giacomo Venezian, 1, 20133 Milano MI

About Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
University Hospital Muenster
1
University Hospital Schleswig-Holstein
1
Total Rows: 3

Clinical Trials at Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


During the past decade, Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122000011002200110000001100Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.
2008-07-29
2019-04-30
Completed
154
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
2010-06-01
2021-12-31
Completed
6,136
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors
2015-11-30
2019-06-06
Terminated
87
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
2016-05-20
2021-07-21
Completed
56
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
2016-05-03
2025-06-15
Active, not recruiting
69
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
2019-08-23
2027-11-22
Recruiting
683
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
2021-01-18
2032-09-25
Recruiting
770
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
2021-09-14
2030-07-03
Recruiting
42

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 6Hoffmann-La Roche: 6University Hospital Muenster: 1University Hospital Muenster: 1University HospitalSchleswig-Holstein: 1University HospitalSchleswig-Holstein: 1

Created with Highcharts 11.1.0Top CollaboratorsDeutsche Krebshilfee.V., Bonn (Germany):2Deutsche Krebshilfee.V., Bonn (Germany):2

Clinical Trials Conditions at Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


According to Clinical.Site data, the most researched conditions in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are "Solid Tumors" (3 trials), "ALK Fusion-positive Solid or CNS Tumors" (1 trials), "CNS Tumors" (1 trials), "Leukemia" (1 trials) and "Lymphoblastic Lymphoma, Childhood" (1 trials). Many other conditions were trialed in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" in a lesser frequency.

Clinical Trials Intervention Types at Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


Most popular intervention types in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are "Drug" (8 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (2 trials), "Atezolizumab" (2 trials), "Entrectinib" (2 trials), "6-Mercaptopurine" (1 trials) and "Belvarafenib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


The vast majority of trials in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica" are 8 trials for "All" genders.

Clinical Trials Status at Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica


Currently, there are NaN active trials in "Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Nazionale Tumori di Milano; S.C. Oncologia Pediatrica, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 1: 4Phase 1: 4Phase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Recruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1